Aura Biosciences Inc (AURA) - News Archive

Aura Biosciences, a cutting-edge biotechnology firm specializing in the development of novel oncology therapies, recently announced highly promising results from its Phase 2 study of bel-sar as a first-line treatment fo...

In an exciting development for the urologic oncology community, Aura Biosciences has announced its plans to host a pivotal investor event on October 17, 2024, where the company will present early data from its ongoing P...

Aura Biosciences has made significant strides in the treatment of early-stage choroidal melanoma, a rare but serious form of eye cancer, by announcing promising Phase 2 end-of-study data regarding their innovative thera...

Aura Biosciences Advances First-Line Treatment for Early-Stage Choroidal Melanoma with Bel-sar in Phase 3 TrialBoston-based biotechnology company, Aura Biosciences Inc. (NASDAQ: AURA), has made a significant breakthroug...